comparemela.com

Page 3 - Phase Iii News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovent thyroid eye therapy hits phase III goal, spurs China NDA

In a crowded thyroid eye disease (TED) space, Innovent Biologics Inc. reported positive late-stage findings for its TED therapy, IBI-311, spurring the Suzhou, China-based biopharma to file for regulatory approval in China.

Bridgebio seeks Japan approval of acoramidis for rare heart disease

Armed with strong phase III safety data in Japanese patients, Palo Alto, Calif.-based Bridgebio Pharma Inc. is planning to file for Japan approval of its investigational drug acoramidis for a rare heart disorder.

Ambitious eCourts Ph-3 project gets Rs 825 crore this fiscal, Rs 1500 crore for next FY

The eCourts Mission Mode Project has been described by the government as the prime mover for improving access to justice using technology. As part of phase-III, the system will be migrated to cloud technology and the cost estimated for providing 25 petabytes (according to existing requirement) of cloud storage is Rs 1,205.20 crore.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.